These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 10203616
1. Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer. Kuczyk MA, Machtens S, Bokemeyer C, Hradil K, Macheel I, Jetscho V, Hartmann J, Thon WF, Jonas U, Serth J. Oncol Rep; 1999; 6(3):687-93. PubMed ID: 10203616 [Abstract] [Full Text] [Related]
2. Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer. Kuczyk MA, Bokemeyer C, Hartmann J, Schubach J, Walter C, Machtens S, Knuchel R, Kollmannsberger C, Jonas U, Serth J. Oncol Rep; 2001; 8(6):1401-7. PubMed ID: 11605074 [Abstract] [Full Text] [Related]
3. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients. Kuczyk M, Machtens S, Hradil K, Schubach J, Christian W, Knüchel R, Hartmann J, Bokemeyer C, Jonas U, Serth J. Br J Cancer; 1999 Nov; 81(6):1052-8. PubMed ID: 10576664 [Abstract] [Full Text] [Related]
4. Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer. Serth J, Kuczyk M, Machtens S, Bokemeyer C, Herrmann R, Hartmann J, Knüchel R, Jonas U. Oncol Rep; 1999 Nov; 6(1):229-33. PubMed ID: 9864434 [Abstract] [Full Text] [Related]
5. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers. Migaldi M, Sgambato A, Garagnani L, Ardito R, Ferrari P, De Gaetani C, Cittadini A, Trentini GP. Clin Cancer Res; 2000 Aug; 6(8):3131-8. PubMed ID: 10955794 [Abstract] [Full Text] [Related]